FDA.reportPublic FDA data

naproxen 125 MG in 5 mL Oral Suspension

RxCUI
311913
RxNorm name
naproxen 125 MG in 5 mL Oral Suspension
Display name
naproxen 125 MG in 5 mL Oral Suspension
Full name
naproxen 125 MG in 5 mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NaproxenNAPROXENAcella Pharmaceuticals, LLC7e6f03fb-4b36-4418-9684-f45637abbb782026-01-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311913
NaproxenNAPROXENAurobindo Pharma Limited570974d4-0d5b-4df2-b307-37380511835d2025-10-07Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311913
NaproxenNAPROXENCamber Pharmaceuticals, Inc.fd5e8d84-f92c-4f4b-ab0d-4cda7cf826bd2025-05-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311913
Naproxen Oral SuspensionNAPROXEN ORALANI Pharmaceuticals, Inc.252726a7-757a-4b97-b5b8-ffff4ac1d1032025-03-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311913
NaproxenNAPROXENHikma Pharmaceuticals USA Inc.a5757b1a-62c9-4421-9794-6fb121ce9b7e2024-12-17Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311913
NaproxenNAPROXENAmneal Pharmaceuticals NY LLC985aedc1-8b3c-4cb4-af13-7203a2b57ab72024-12-02Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311913

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a5757b1a-62c9-4421-9794-6fb121ce9b7enaproxen 125 MG in 5 mL Oral Suspension [PSN] · naproxen 25 MG/ML Oral Suspension [SCD] · naproxen 125 MG per 5 ML Oral Suspension [SY]311These highlights do not include all the information needed to use NAPROXEN ORAL SUSPENSION safely and effectively. See full prescribing information for NAPROXEN ORAL SUSPENSION. NAPROXEN oral suspension, for oral use Initial U.S. Approval: 197620241217
985aedc1-8b3c-4cb4-af13-7203a2b57ab7naproxen 125 MG in 5 mL Oral Suspension [PSN] · naproxen 25 MG/ML Oral Suspension [SCD] · naproxen 125 MG per 5 ML Oral Suspension [SY]310These highlights do not include all the information needed to use NAPROXEN ORAL SUSPENSION safely and effectively. See full prescribing information for NAPROXEN ORAL SUSPENSION. NAPROXEN oral suspension Initial U.S. Approval: 197620241202
7e6f03fb-4b36-4418-9684-f45637abbb78naproxen 125 MG in 5 mL Oral Suspension [PSN] · naproxen 25 MG/ML Oral Suspension [SCD] · naproxen 125 MG per 5 ML Oral Suspension [SY]34These highlights do not include all the information needed to use NAPROXEN SUSPENSION safely and effectively. See full prescribing information for NAPROXEN SUSPENSION. NAPROXEN suspension, for oral use Initial U.S. Approval: 197620260105
fd5e8d84-f92c-4f4b-ab0d-4cda7cf826bdnaproxen 125 MG in 5 mL Oral Suspension [PSN] · naproxen 25 MG/ML Oral Suspension [SCD] · naproxen 125 MG per 5 ML Oral Suspension [SY]34These highlights do not include all the information needed to use NAPROXEN ORAL SUSPENSION safely and effectively. See full prescribing information for NAPROXEN ORAL SUSPENSION. NAPROXEN oral suspension, for oral use Initial U.S. Approval: 197620250506
252726a7-757a-4b97-b5b8-ffff4ac1d103naproxen 125 MG in 5 mL Oral Suspension [PSN] · naproxen 25 MG/ML Oral Suspension [SCD] · naproxen 125 MG per 5 ML Oral Suspension [SY]33These highlights do not include all the information needed to use NAPROXEN ORAL SUSPENSION safely and effectively. See full prescribing information for NAPROXEN ORAL SUSPENSION. NAPROXEN oral suspension, for oral use Initial U.S. Approval: 197620250325
570974d4-0d5b-4df2-b307-37380511835dnaproxen 125 MG in 5 mL Oral Suspension [PSN] · naproxen 25 MG/ML Oral Suspension [SCD] · naproxen 125 MG per 5 ML Oral Suspension [SY]31These highlights do not include all the information needed to use NAPROXEN ORAL SUSPENSION safely and effectively. See full prescribing information for NAPROXEN ORAL SUSPENSION. NAPROXEN oral suspension Initial U.S. Approval: 197620251007